Hepatic Disease Clinical Trial
Official title:
Paracetamol Metabolism Research in Postoperative Hepatic Surgery
The main objective of this study was to evaluate the 5-day kinetics of plasma paracetamol
levels in postoperative major hepatic surgery (resection greater than or equal to three
hepatic segments) compared with less extensive liver resection and hepatic re-intervention.
The clearance of indocyanine green is a marker of hepatic perfusion but also of the proper
hepatocyte functioning, if hemodynamic conditions are stable.
Some patients may be operated on up to four or five times in the liver. Moreover, these
patients probably present an increased risk of postoperative hepatocellular insufficiency due
to a quantitative and qualitative decrease in their hepatic parenchyma. It is therefore
interesting to evaluate the use of paracetamol in this situation.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05593211 -
Assess Safety and Performance of the Kronos Electrocautery Device for Electrocautery Procedures Following Coaxial Biopsy Procedures
|
N/A | |
Terminated |
NCT02104154 -
Evaluation of the Samsung LABGEO PT10 Hepatic Panel in a Point-of-Care Setting
|
N/A | |
Not yet recruiting |
NCT06153394 -
Prolonged Hypercoagulability Following Major Liver Resection for Malignancy
|
Phase 3 | |
Completed |
NCT03652636 -
Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions
|
Phase 4 | |
Recruiting |
NCT05822635 -
SpyGlass Surgical Study
|
||
Not yet recruiting |
NCT05616442 -
Ketotifen in Non-Alcoholic Fatty Liver Disease Patients
|
Phase 4 | |
Completed |
NCT03767517 -
A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders
|
N/A |